Clinical Trial Details
| Trial ID: | L1390 |
| Source ID: | NCT00053547 |
| Associated Drug: | Paricalcitol Injection |
| Title: | Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Secondary Hyperparathyroidism|End Stage Renal Disease |
| Interventions: | DRUG: paricalcitol injection |
| Outcome Measures: | Primary: Proportion of subjects achieving at least a 30% decrease from baseline iPTH sustained for at least two consecutive iPTH measurements. | Secondary: Proportion of subjects in each group who achieve two consecutive iPTH values below 300 pg/mL. |
| Sponsor/Collaborators: | Sponsor: Abbott |
| Gender: | ALL |
| Age: | CHILD, ADULT |
| Phases: | PHASE4 |
| Enrollment: | 28 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: TREATMENT |
| Start Date: | 2002-01 |
| Completion Date: | |
| Results First Posted: | |
| Last Update Posted: | 2006-08-02 |
| Locations: | Stanford University Medical Center, Stanford, California, 94305, United States|Miami Children's Hospital, Miami, Florida, United States|The Children's Hospital of Buffalo, Buffalo, New York, United States|Texas Children's Hospital, Houston, Texas, United States|University of Texas at Houston, Houston, Texas, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States |
| URL: | https://clinicaltrials.gov/show/NCT00053547 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|